Martingale Asset Management’s Puma Biotechnology PBYI Stock Holding History
Bought
Maintained
Sold
Other funds holding PBYI
ACA
Martingale Asset Management's PBYI Position: Q3 2026 in Review
Martingale Asset Management increased its Puma Biotechnology (PBYI) stake by 145% in Q3 2026, buying an estimated $324K and bringing the position to 62,127 shares worth $617K. The position accounts for 0.02% of the portfolio, ranked #626.
Martingale Asset Management first reported a position in PBYI in Q4 2014 and has held it in 3 quarters since. 156 funds tracked by Wall St. Rank hold PBYI as of Q3 2026.
- Martingale Asset Management held 62,127 shares of Puma Biotechnology worth $617K as of Q3 2026.
- Martingale Asset Management bought 36,763 Puma Biotechnology shares in Q3 2026, an estimated $324K.
- Puma Biotechnology made up 0.02% of Martingale Asset Management's portfolio in Q3 2026, its #626 holding.
- Martingale Asset Management first reported a position in Puma Biotechnology in Q4 2014 and has held it in 3 quarters since.
- 156 funds tracked by Wall St. Rank held Puma Biotechnology as of Q3 2026.
Based on Martingale Asset Management's 13F filing for Q3 2026, filed 12 Nov 2026.